North America Advanced Drug Delivery Systems Market - Growth, Trends, and Forecast (2019 - 2024)

The market is segmented by Type, Application, Technology (Prodrug, Implants, and Intrauterine Devices, Targeted Drug Delivery, Polymeric Drug Delivery, Other Technologies), and Geography

Market Snapshot

Picture1North America Advanced Drug Delivery Systems
Study Period:

2016-2024

Base Year:

2018

CAGR:

4.8 %

Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

North America drug delivery systems market is expected to register a CAGR of around 4.8 % during the forecast period, 2019 - 2024. The factors that are driving this market include the development of new drugs and biologics, advancements in understanding human biology and diseases, and increased R&D spending. Furthermore, increasing disease burden across the world, the proven efficacy of controlled-release drug delivery systems in addressing a wide range of diseases, and the growing R&D trends by both the innovators and the generic players for advanced drug delivery systems, are propelling the growth of the market. However, factors such as product recall of advanced drug delivery products and challenges in nanomedicine based drug delivery act as a major restraint to the market growth.

Scope of the Report

The concept of advanced drug delivery system is to increase the efficacy of drugs. Advanced drug delivery systems are adopted to increase the bioavailability of the drug, reduce adverse effects and side effects, and increase drug stability.

Type
Oral Drug Delivery System
Injection-based Drug Delivery System
Inhalation/Pulmonary Drug Delivery System
Transdermal Drug Delivery System
Trans mucosal Drug Delivery System
Carrier-based Drug Delivery System
Other Types
Application
Cardiovascular Diseases
Oncology
Urology
Diabetes
CNS
Ophthalmology
Inflammatory Diseases
Infections
Other Applications
Technology
Prodrug
Implants and Intrauterine Devices
Targeted Drug Delivery
Polymeric Drug Delivery
Other Technologies
Geography
North America
US
Canada
Mexico

Report scope can be customized per your requirements. Click here.

Key Market Trends

Injection-based Drug Delivery System dominates the North America Advanced Drug Delivery Systems Market

The technological advancement processes have resulted in the advent of improved and enhanced devices, as well as equipment that is tailor-made and specific to different categories of patient care. In addition, technological innovations, like dual-injectable drug delivery system, have further enhanced the method of drug delivery. They also offer many features and functions that improve usability, safety, efficacy, and compliance, as well as many other functions, such as connectivity and even diagnostics. With the advent of self-injection devices, like auto-injectors, pen-injectors, and needle-free injectors, the use of injectable drug delivery (IDD) has been made relatively easy, allowing patients to administer drugs at home without medical assistance. The increase in the number of diabetic patients has allowed the majority of the leading players in this market to launch devices for the administration of insulin, with the help of self-injection devices. Thus, the homecare settings contribute as the largest end users for injectable drug delivery systems.

North America Advanced Drug Delivery Systems Market

To understand key trends, Download Sample Report

Competitive Landscape

North America advanced drug delivery systems market is moderately competitive. Some of the major players in this market are Boston Scientific Corporation, Baxter International, 3M, Abbott Laboratories, and GlaxoSmithKline PLC. Owing to the continuous technological advancements in the drug delivery system, there is a possibility of new entrants in the market in the coming future.

Major Players

  1. 3M
  2. Aradigm Corporation
  3. Pfizer Inc.
  4. Boston Scientific Corporation
  5. West Pharmaceutical Services, Inc.

* Complete list of players covered available in the table of contents below

North America Advanced Drug Delivery Systems Market Image 3

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Development of New Drugs and Biologics

      2. 4.2.2 Advancements in Understanding Human Biology and Diseases

      3. 4.2.3 Increased R&D Spending

    3. 4.3 Market Restraints

      1. 4.3.1 Product Recalls of Advanced Drug Delivery Products

      2. 4.3.2 Challenges in Nanomedicine-based Drug Delivery

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Type

      1. 5.1.1 Oral Drug Delivery System

      2. 5.1.2 Injection-based Drug Delivery System

      3. 5.1.3 Inhalation/Pulmonary Drug Delivery System

      4. 5.1.4 Transdermal Drug Delivery System

      5. 5.1.5 Trans mucosal Drug Delivery System

      6. 5.1.6 Carrier-based Drug Delivery System

      7. 5.1.7 Other Types

    2. 5.2 Application

      1. 5.2.1 Cardiovascular Diseases

      2. 5.2.2 Oncology

      3. 5.2.3 Urology

      4. 5.2.4 Diabetes

      5. 5.2.5 CNS

      6. 5.2.6 Ophthalmology

      7. 5.2.7 Inflammatory Diseases

      8. 5.2.8 Infections

      9. 5.2.9 Other Applications

    3. 5.3 Technology

      1. 5.3.1 Prodrug

      2. 5.3.2 Implants and Intrauterine Devices

      3. 5.3.3 Targeted Drug Delivery

      4. 5.3.4 Polymeric Drug Delivery

      5. 5.3.5 Other Technologies

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 US

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 3M

      2. 6.1.2 Aradigm Corporation

      3. 6.1.3 Amgen Inc

      4. 6.1.4 Astrazeneca PLC

      5. 6.1.5 Bayer Healthcare

      6. 6.1.6 Boston Scientific Corporation

      7. 6.1.7 Pfizer Inc

      8. 6.1.8 Merck & Co, Inc

      9. 6.1.9 Novartis AG

      10. 6.1.10 West Pharmaceutical Services, Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please Enter a Valid Message!


Complete your payment details below

Shipping & Billing Information

Payment Information